MS is a chronic, inflammatory, demyelinating, autoimmune disease of the central nervous system. It is among the most common causes of neurological disability in young adults and occurs at least twice as frequently in women as in men.
More than 150,000 patients are believed to suffer from MS currently in the MENA region. The incidence and prevalence of this debilitating disease continue to rise in the region as observed by several local epidemiology publications and patient registries. Although we have seen a leap in disease awareness, we continue to learn and develop our understanding of the underlying causes, disease progression and treatment alternatives. There is no doubt that more can be done to improve our understanding of the disease characteristics and their impact on the diverse population inhabiting the MENA region.